On the front tonightBioNTech to close three German plants after failing to find buyers
Today's story
BioNTech and Roche to present new cancer drug data at ESMO 2026
BioNTech plans to present 16 oncology abstracts at ESMO 2026, including Phase 2 data on pumitamig combinations in advanced cancers and a trial of pumitamig plus docetaxel for metastatic lung cancer. Roche’s Genentech will present late-stage findings on divarasib in KRAS G12C-mutated lung cancer, giredestrant in breast cancer and its experimental Tam-Peli therapy.
Health · 7 sources · Oct 19, 2026Read it
The journal
Open the journal →The conversation starts in the journal — be the first to post.
About BioNTech
BioNTech SE is a German multinational biotechnology company headquartered in Mainz that develops immunotherapies and vaccines, particularly for cancer and infectious diseases.
Everything about BioNTech →- Country
- Germany
- Headquarters
- Mainz
- Inception
- June 2008
- Website
- https://biontech.de/